Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.65
Bid: 3.60
Ask: 3.70
Change: -0.04 (-1.08%)
Spread: 0.10 (2.778%)
Open: 4.00
High: 4.05
Low: 3.65
Prev. Close: 3.69
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

Thu, 24th Sep 2020 16:35

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

----------

Supply@Me Capital PLC - fintech platform which provides inventory monetisation - Chief Executive Officer Alessandro Zamboni - via Orchestra Group, which he owns - on Wednesday buys option to receive 630.0 million shares if share price is above 0.6945 pence on December 31. The option costs GBP1.1 million. Supply@Me's current share price is 0.5100p, down from 1.1000p in March but up from 0.0500p in August. Supply@Me separately says Orchestra Group holds 27.89% of the company. On Monday, Supply@Me said it had entered into strategic pact with a "leading European alternative investment firm" and shareholders 1AF2 Srl and AvantGarde Group SpA to acquire a bank in Europe. Supply@Me to give the bank rights to invest in securitisation note issues and in exchange, the bank will provide up to EUR8 billion of funding over five years. Supply@Me will not be shareholder in bank and will bear no costs related to the transaction. Milan-based Supply@Me reversed into AIM stock Abal Group PLC and relisted on the London Main Market back in March.

----------

WPP PLC - London-based advertising and marketing group - CEO Mark Read buys 85,000 shares at GBP5.67 on Thursday, and Chief Financial Officer John Rogers buys 75,838 shares at GBP5.88 on Wednesday. Together worth GBP928,209.

----------

Funding Circle Holdings PLC - London-based platform for investors to lend to small businesses - CEO Samir Desai buys 163,017 shares at average GBP0.62, worth GBP101,098, on Thursday. Funding Circle on Thursday posted a GBP115.1 million pretax loss for the six months ended June 30, dramatically widened from a GBP30.8 million loss a year before.

----------

Beazley PLC - London-based specialist insurance - Non-Executive Director Andrew Likierman buys 10,000 shares at 326.05 pence, worth GBP32,605, on Wednesday.

----------

Polymetal International PLC - Non-Executive Director Konstantin Yanakov buys 2,421 shares at RUB1,649.02, worth RUB4.0 million, about GBP40,465, on Tuesday.

----------

eve Sleep PLC - London-based direct-to-consumer mattress retailer - CEO Cheryl Calverley buys 92,785 shares at average 4.85p, worth GBP4,500, on Tuesday. Now has 280,285 shares.

----------

Fusion Antibodies PLC - Belfast-based antibody engineering for therapeutic drug and diagnostic applications - Non-Executive Director Alan Mawson sells 20,000 shares at 180p, worth GBP36,000, on Wednesday. Still has 124,000 shares, an 0.5% stake.

----------

SIG PLC - London-based supplier of specialist construction products - CEO Stephen Francis buys 208,000 shares at 24.0p and Susan Allner, associate of Chair Andrew Allner, buys 40,000 shares at 24.1p, both on Thursday and together worth GBP59,520.

----------

Sanne Group PLC - London-based fund and corporate services - Non-Executive Director Yves Stein buys 5,000 shares at GBP5.80, worth GBP29,000, on Wednesday.

----------

WANdisco PLC - Sheffield, England and San Ramon, California-based cloud-based data management platform - Non-Executive Director Grant Dollens buys 200,000 shares via Global Frontier Partners LP at average GBP4.48, worth GBP896,000, on Wednesday. Now has 2.4 million shares, a 4.5% stake.

----------

Dechra Pharmaceuticals PLC - Cheshire-based veterinary products - Tony Griffin, managing director of Dechra Veterinary Products EU, sells 4,400 shares at GBP32.03, worth GBP140,915, on Wednesday. Still has 70,650 shares.

----------

Workspace Group PLC - London-based office and studio space provider - CFO Dave Benson buys 19,850 shares at 501.18p, worth GBP99,485, on Wednesday. Benson joined Workspace from Premier Inn-owner Whitbread PLC in April.

----------

Caledonia Mining Corp PLC - southern Africa-focused exploration and development company - Chair Leigh Wilson sells 12,000 shares at USD17.32, worth USD207,840, on Tuesday. Still has 40,000 shares.

----------

Gresham House Strategic PLC - investor in smaller UK public companies - Chair David Potter buys 2,526 shares at 989p, worth GBP24,982, on Tuesday. He now has 24,882 shares. Three other non-executive directors buy a total 4,440 at 979p, also on Tuesday.

----------

Yourgene Health PLC - Manchester-based molecular diagnostics - Chair Adam Reynolds buys 294,117 shares and CEO Lyn Rees buys 294,000 shares, both at 17p and together worth GBP99,980, on Wednesday. Reynolds now has 6.7 million shares and Rees 1.0 million. Three Yourgene directors had bought a total of 205,260 shares on Tuesday.

----------

Maestrano Group PLC - London-based cloud platform for data management and business analytics - Three directors - John David, Jonathan Macleod and Nicholas McInnes - each buy 150,000 shares at 10p, together worth GBP45,000, on Wednesday. The purchases were part of 1.7 million shares sold by David Israel in order to reduce the holding of the concert party of which he is a member down to 46.7% from 47.8%. Maestrano says the concert party had "inadvertently" triggered the obligation to make a general offer for the company back in March. In compensation for reducing his stake, Israel is issued an equivalent number of share options.

----------

TI Fluid Systems PLC - Oxford-based products that store and move fluids such as fuel and brake fluid around automobiles - Independent Non-Executive Director John Smith buys 40,300 shares at GBP1.35, worth GBP54,292, on Tuesday.

----------

Rosslyn Data Technologies PLC - London-based cloud enterprise data analytics platform - Founder & Chief Information Officer Hugh Cox buys 110,000 shares at 5.89p, worth GBP6,479, on Wednesday. Now has 11.5 million shares, a 3.4% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
28 Apr 2020 11:19

Fusion Antibodies raises £3m for Covid-19 research

(Sharecast News) - Fusion Antibodies has raised £3m from investors to extend its research to cover potential treatments for Covid-19.

Read more
30 Mar 2020 16:52

Fusion Antibodies Trading In Line With Expectations Amid Outbreak

Fusion Antibodies Trading In Line With Expectations Amid Outbreak

Read more
17 Mar 2020 15:54

DIRECTOR DEALINGS SUMMARY: IWG And Man Chiefs Buy GBP3 Million Worth

DIRECTOR DEALINGS SUMMARY: IWG And Man Chiefs Buy GBP3 Million Worth

Read more
3 Feb 2020 17:32

DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Boss Buys GBP200,000 Worth

DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Boss Buys GBP200,000 Worth

Read more
29 Jan 2020 13:35

Fusion Antibodies Expects Annual Revenue Rise Ahead Of Expectations

Fusion Antibodies Expects Annual Revenue Rise Ahead Of Expectations

Read more
29 Jan 2020 09:32

Fusion Antibodies sees 'favourable trends' continue in H2

(Sharecast News) - Pre-clinical therapeutic drug and diagnostics firm Fusion Antibodies said on Wednesday that trading in the third quarter of the financial year had continued the "favourable trends" experienced in the first half.

Read more
10 Jan 2020 12:09

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Mawson Buys Shares

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Mawson Buys Shares

Read more
3 Dec 2019 18:08

DIRECTOR DEALINGS: Fusion Antibodies Non-Exec Mawson Buys Shares

DIRECTOR DEALINGS: Fusion Antibodies Non-Exec Mawson Buys Shares

Read more
2 Dec 2019 11:27

Fusion Antibodies cuts losses after revenue leaps

(Sharecast News) - Fusion Antibodies on Monday reported a narrowed loss after revenue more than doubled following the launch of its RAMP service.

Read more
2 Dec 2019 10:49

Fusion Antibodies Revenue Takes Off But Order Visibility Cloudy

Fusion Antibodies Revenue Takes Off But Order Visibility Cloudy

Read more
22 Oct 2019 15:13

Fusion Antibodies pleased with progress in first half

(Sharecast News) - Preclinical antibody discovery company Fusion Antibodies updated the market on the six months ended 30 September on Tuesday, reporting continued revenue growth amid the commercial roll out of new services.

Read more
22 Oct 2019 14:31

Fusion Antibodies Predicts Rise In Interim Revenue And Orders

Fusion Antibodies Predicts Rise In Interim Revenue And Orders

Read more
3 Jul 2019 17:03

DIRECTOR DEALINGS: Fusion Antibodies CEO, Non-Executives Buy Shares

(Alliance News) - Fusion Antibodies PLC said Wednesday that its Chief Executive Officer and two Non-Executive Directors have bought around GBP31,794 in shares in the company in deals on Executive

Read more
2 Jul 2019 10:46

Fusion Antibodies Annual Loss Widens After Rocky First Half

(Alliance News) - Fusion Antibodies PLC on Tuesday said its loss gapped wider after a weak first half brought annual revenue down 19%, though this was followed by a much stronger second antibody a

Read more
17 Apr 2019 11:49

Fusion Antibodies Annual Revenue Declines On Weak First Half

LONDON (Alliance News) - Fusion Antibodies PLC on Wednesday reported an improved performance in the second half of its recently ended financial year after "disappointing" first company a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.